efficacy & safety of ofatumumab vs teriflunomide in relapsing ms: phase 3 asclepios i&ii trials
Published 4 years ago • 536 plays • Length 14:13Download video MP4
Download video MP3
Similar videos
-
4:56
post hoc analysis: phase 3 asclepios i and ii trials in relapsing ms
-
43:44
barts ms journal club 26 jan 2021 ide smets ofatumumab vs teriflunomide
-
14:03
kesimpta (ofatumumab) for multiple sclerosis [asclepios i/ii trial results]
-
2:13
is long-term teriflunomide treatment safe in ms?
-
2:07
jeffrey cohen, md: ofatumumab’s potential role in ms care
-
4:51
teriflunomide shows benefits in longterm care of multiple sclerosis
-
5:42
comparing ublituximab and teriflunomide in improving fatigue in ms
-
1:26
teriflunomide shows promise as potential treatment for radiologically isolated syndrome
-
0:45
teriflunomide to treat relapsing forms of multiple sclerosis - overview
-
1:51
safety and efficacy of ahsct for ms
-
5:47
efficacy of ropeginterferon in mf
-
19:07
#070: teriflunomide (aubagio) for relapsing remitting ms
-
5:52
longterm studies of aubagio continue to show safety for multiple sclerosis treatment
-
20:54
should we still use aubagio to treat multiple sclerosis? [2019]
-
2:12
terikids study: teriflunomide in pediatric patients with relapsing ms
-
0:13
accoson 6 inch aneroid sphyg desk model with velcro cuff ac0332
-
1:35
biosimilars: safety & efficacy
-
3:13
aubagio and preganancy
-
4:57
safety and efficacy: elotuzumab